Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. USO
10. MSTR

Go back to Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Misses Q1 EPS by 5c

May 7, 2020 5:29 PM EDT

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.56), $0.05 worse than the analyst estimate of ($0.51).

"During the first quarter, we generated significant momentum that we believe will take us through what we expect will be a transformational year for Syndax, with key data readouts expected across the entirety of our portfolio," said... More